TrialModern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc2015

Impact of updated HER2 testing guidelines in breast cancer--re-evaluation of HERA trial fluorescence in situ hybridization data.

Oliver C Stoss et al.PubMed ↗Publisher ↗

No numbers read from the abstract.